Gisslén M - Search Results

1

High Cellular Monocyte Activation in People Living With Human Immunodeficiency Virus on Combination Antiretroviral Therapy and Lifestyle-Matched Controls Is Associated With Greater Inflammation in Cerebrospinal Fluid.

Booiman T, Wit FW, Maurer I, De Francesco D, Sabin CA, Harskamp AM, Prins M, Garagnani P, Pirazzini C, Franceschi C, Fuchs D, Gisslén M, Winston A, Reiss P, Kootstra NA; Comorbidity in Relation to AIDS (COBRA) Collaboration. Booiman T, et al. Among authors: gisslen m. Open Forum Infect Dis. 2017 May 25;4(3):ofx108. doi: 10.1093/ofid/ofx108. eCollection 2017 Summer. Open Forum Infect Dis. 2017. PMID: 28680905 Free PMC article.

2

Tryptophan concentrations increase in cerebrospinal fluid and blood after zidovudine treatment in patients with HIV type 1 infection.

Gisslén M, Larsson M, Norkrans G, Fuchs D, Wachter H, Hagberg L. Gisslén M, et al. AIDS Res Hum Retroviruses. 1994 Aug;10(8):947-51. doi: 10.1089/aid.1994.10.947. AIDS Res Hum Retroviruses. 1994. PMID: 7529033

3

Markers of immune stimulation in the cerebrospinal fluid during HIV infection: a longitudinal study.

Gisslén M, Chiodi F, Fuchs D, Norkrans G, Svennerholm B, Wachter H, Hagberg L. Gisslén M, et al. Scand J Infect Dis. 1994;26(5):523-33. doi: 10.3109/00365549409011810. Scand J Infect Dis. 1994. PMID: 7855550

4

Intrathecal immunoactivation in patients with HIV-1 infection is reduced by zidovudine but not by didanosine.

Hagberg L, Norkrans G, Gisslen M, Wachter H, Fuchs D, Svennerholm B. Hagberg L, et al. Among authors: gisslen m. Scand J Infect Dis. 1996;28(4):329-33. doi: 10.3109/00365549609037914. Scand J Infect Dis. 1996. PMID: 8893393 Clinical Trial.

5

Increase of tryptophan in serum and in cerebrospinal fluid of patients with HIV infection during zidovudine therapy.

Fuchs D, Gisslén M, Larsson M, Norkrans G, Hagberg L, Wachter H. Fuchs D, et al. Among authors: gisslen m. Adv Exp Med Biol. 1996;398:131-4. doi: 10.1007/978-1-4613-0381-7_21. Adv Exp Med Biol. 1996. PMID: 8906255

6

The effect on human immunodeficiency virus type 1 RNA levels in cerebrospinal fluid after initiation of zidovudine or didanosine.

Gisslén M, Norkrans G, Svennerholm B, Hagberg L. Gisslén M, et al. J Infect Dis. 1997 Feb;175(2):434-7. doi: 10.1093/infdis/175.2.434. J Infect Dis. 1997. PMID: 9203666

7

Cerebrospinal fluid viral load in HIV-1-infected patients without antiretroviral treatment: a longitudinal study.

Gisslén M, Hagberg L, Fuchs D, Norkrans G, Svennerholm B. Gisslén M, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Apr 1;17(4):291-5. doi: 10.1097/00042560-199804010-00001. J Acquir Immune Defic Syndr Hum Retrovirol. 1998. PMID: 9525428

8

Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection.

Gisslén M, Fuchs D, Svennerholm B, Hagberg L. Gisslén M, et al. J Acquir Immune Defic Syndr. 1999 Aug 1;21(4):271-6. doi: 10.1097/00126334-199908010-00003. J Acquir Immune Defic Syndr. 1999. PMID: 10428104

9

Increased cerebrospinal fluid protein tau concentration in neuro-AIDS.

Andersson L, Blennow K, Fuchs D, Svennerholm B, Gisslén M. Andersson L, et al. Among authors: gisslen m. J Neurol Sci. 1999 Dec 15;171(2):92-6. doi: 10.1016/s0022-510x(99)00253-1. J Neurol Sci. 1999. PMID: 10581374

10

Intrathecal immune activation is associated with cerebrospinal fluid markers of neuronal destruction in AIDS patients.

Hagberg L, Fuchs D, Rosengren L, Gisslén M. Hagberg L, et al. Among authors: gisslen m. J Neuroimmunol. 2000 Jan 3;102(1):51-5. doi: 10.1016/s0165-5728(99)00150-2. J Neuroimmunol. 2000. PMID: 10626666

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

295 results

Search Page